bortezomib 1 MG Injection

RxCUI: 2601542
RxNorm name: bortezomib 1 MG Injection
Display name: bortezomib 1 MG Injection
Full name: bortezomib 1 MG Injection
Term type: SCD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:21

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Bortezomib	BORTEZOMIB	Gland Pharma Limited	cd698074-da21-4b53-8f6b-241535a8d598	2026-01-08	Warnings, Adverse reactions	Exact identifier rxcui: 2601542
BORTEZOMIB	BORTEZOMIB	Hospira, Inc.	9fdf6169-699f-40eb-bda1-760253062b3c	2023-02-27	Warnings, Adverse reactions	Exact identifier rxcui: 2601542

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
cd698074-da21-4b53-8f6b-241535a8d598	bortezomib 1 MG Injection [PSN] · bortezomib 1 MG Injection [SCD]	2	4	These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 2003	20260108
9fdf6169-699f-40eb-bda1-760253062b3c	bortezomib 1 MG Injection [PSN] · bortezomib 1 MG Injection [SCD]	2	3	These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 2003	20230227